Collaboration combines strengths to develop and commercialize life-saving antifungal treatment and prophylaxis, an area of high unmet medical need Read More »

CTP-543 Achieved its Primary Endpoint in the 8 mg and 12 mg Twice-Daily Dosing Cohorts Read More »

Grane Rx--the leading provider of senior care pharmacy solutions--proudly celebrates 25 years in business this month. Grane Rx opened its doors in 1994 to serve Pennsylvanians and today serves more than 11,500 residents and participants across 70+ facilities nationwide. Read More »

New Board Members Also Announced, Including Representatives from AstraZeneca, UCB, and US Bioservices2019-2020 NASP President-Elect Announced Read More »

Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, announced today that Dr. Mahesh Patel, Chairman, President and CEO, will participate in the Oppenheimer & Co. Fall Summit Focused on Specialty Pharma, Rare Disease & Gene Therapy, being held September 23-24, 2019 in New York City. Read More »

Partner Therapeutics, Inc. (PTx), a commercial biotechnology company, announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Leukine® (sargramostim), a yeast-derived recombinant human granulocyte-macrophage colony stimulating factor (rhuGM-CSF), for the potential treatment of Stage IIb-IV melanoma. Read More »

TWILIGHT Study Fails to Answer Key Scientific Question Regarding Most Efficacious Treatment Post-PCI Read More »

Acquisition is expected to realize over $10M in annual synergies Read More »